These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 221074)

  • 21. Behavioral and neurochemical correlates of repeated d-amphetamine administration.
    Segal DS
    Adv Biochem Psychopharmacol; 1975; 13():247-62. PubMed ID: 1171583
    [No Abstract]   [Full Text] [Related]  

  • 22. Biochemical and behavioral antagonism between fenfluramine and apomorphine in rats.
    Jori A; Cecchetti G; Ghezzi D; Samanin R
    Eur J Pharmacol; 1974 May; 26(2):179-83. PubMed ID: 4859224
    [No Abstract]   [Full Text] [Related]  

  • 23. Various effects of d-amphetamine in rats with selective lesions of brain noradrenaline - containing neurons or treated with penfluridol.
    Quattrone A; Bendotti C; Recchia M; Samanin R
    Commun Psychopharmacol; 1977; 1(6):525-31. PubMed ID: 564765
    [No Abstract]   [Full Text] [Related]  

  • 24. Neurotensin effects on brain dopaminergic systems.
    Haubrich DR; Martin GE; Pflueger AB; Williams M
    Brain Res; 1982 Jan; 231(1):216-21. PubMed ID: 7198926
    [No Abstract]   [Full Text] [Related]  

  • 25. Spontaneous and amphetamine-induced behavior after bilateral injection of ethanolamine-O-sulfate into the substantia nigra.
    Koob GF; Del Fiacco M; Iversen SD
    Brain Res; 1978 May; 146(2):313-23. PubMed ID: 565665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modification of amphetamine effects by intracerebrally administered anticholinergic agents.
    Costall B; Naylor RJ
    Life Sci I; 1972 Mar; 11(5):239-53. PubMed ID: 4675889
    [No Abstract]   [Full Text] [Related]  

  • 27. In vivo electrochemical and behavioral evidence for specific neural substrates modulated differentially by enkephalin in rat stimulant stereotypy and locomotion.
    Broderick PA; Gardner EL; van Praag HM
    Biol Psychiatry; 1984 Jan; 19(1):45-54. PubMed ID: 6538442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concomitant sensitization of amphetamine-induced behavioral stimulation and in vivo dopamine release from rat caudate nucleus.
    Patrick SL; Thompson TL; Walker JM; Patrick RL
    Brain Res; 1991 Jan; 538(2):343-6. PubMed ID: 2012977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical and behavioral changes in rats during and after chronic d-amphetamine exposure.
    Vogel WH; Miller J; Waxman H; Gottheil E
    Drug Alcohol Depend; 1985 Jun; 15(3):245-53. PubMed ID: 4040845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue level related stereotyped behaviour after intravenous amphetamine in rats.
    Dahl CB; Götestam KG
    Acta Pharmacol Toxicol (Copenh); 1986 Mar; 58(3):169-74. PubMed ID: 3716811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Animal models of amphetamine psychosis: neurotransmitter release from rat brain slices.
    Lillrank SM; Oja SS; Saransaari P; Seppälä T
    Int J Neurosci; 1991 Sep; 60(1-2):1-15. PubMed ID: 1685488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioral effects of amphetamine in a group of rhesus monkeys with lesions of dorsolateral frontal cortex.
    Miller MH
    Psychopharmacology (Berl); 1976 May; 47(1):71-4. PubMed ID: 822440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopaminergic neurons in the nigro-striatal and mesolimbic pathways: mediation of specific effects of D-amphetamine.
    Yehuda S; Wurtman RJ
    Eur J Pharmacol; 1975 Feb; 30(2):154-8. PubMed ID: 1168575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereotyped behavior and diabetes mellitus in rats: reduced behavioral effects of amphetamine and apomorphine and reduced in vivo brain binding of [3H]spiroperidol.
    Rowland N; Joyce JN; Bellush LL
    Behav Neurosci; 1985 Oct; 99(5):831-41. PubMed ID: 3916385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of amphetamines on the metabolism of catecholamines in the rat brain.
    Baldessarini RJ; Harris JE
    J Psychiatr Res; 1974; 11():41-3. PubMed ID: 4477777
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of acute and chronic injections of d-amphetamine sulfate and substantia nigra lesions on the distribution of amphetamine and para-hydroxyamphetamine in the rat brain.
    Danielson TJ; Petrali EH; Wishart TB
    Life Sci; 1976 Oct; 19(8):1265-9. PubMed ID: 994725
    [No Abstract]   [Full Text] [Related]  

  • 38. A neuropharmacological analysis of central nervous system catecholamine systems in development protein malnutrition.
    Leahy JP; Stern WC; Resnick O; Morgane PJ
    Dev Psychobiol; 1978 Jul; 11(4):361-70. PubMed ID: 566687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic lithium treatment and dopamine-mediated behavior.
    Ebstein RP; Eliashar S; Belmaker RH; Ben-Uriah Y; Yehuda S
    Biol Psychiatry; 1980 Jun; 15(3):459-67. PubMed ID: 7189675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of dose-dependent effects of acute amphetamine administration on behavior and local cerebral metabolism in rats.
    Porrino LJ; Lucignani G; Dow-Edwards D; Sokoloff L
    Brain Res; 1984 Jul; 307(1-2):311-20. PubMed ID: 6540614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.